Explainable Artificial Intelligence in Neuroimaging of Alzheimer’s Disease
Объяснимый искусственный интеллект в нейровизуализации болезни Альцгеймера
2025-03-04
SCID: 54.1/9yb8wzwz
Discuss with AI
Alzheimer’s diseaseGrad-CAMSHAPexplainable artificial intelligenceneuroimaging
Figures from the paper
Abstract (AI)
Alzheimer's disease (AD) remains a significant global health challenge, affecting millions worldwide and imposing substantial burdens on healthcare systems. Advances in artificial intelligence (AI), particularly in deep learning and machine learning, have revolutionized neuroimaging-based AD diagnosis. However, the complexity and lack of interpretability of these models limit their clinical applicability. Explainable Artificial Intelligence (XAI) addresses this challenge by providing insights into model decision-making, enhancing transparency, and fostering trust in AI-driven diagnostics. This review explores the role of XAI in AD neuroimaging, highlighting key techniques such as SHAP, LIME, Grad-CAM, and Layer-wise Relevance Propagation (LRP). We examine their applications in identifying critical biomarkers, tracking disease progression, and distinguishing AD stages using various imaging modalities, including MRI and PET. Additionally, we discuss current challenges, including dataset limitations, regulatory concerns, and standardization issues, and propose future research directions to improve XAI's integration into clinical practice. By bridging the gap between AI and clinical interpretability, XAI holds the potential to refine AD diagnostics, personalize treatment strategies, and advance neuroimaging-based research.
Key Findings
1
Dataset limitations, regulatory concerns, and insufficient standardization currently hinder the integration of XAI into clinical practice.
2
Explainable artificial intelligence can improve the transparency and clinical trustworthiness of AI-based neuroimaging diagnostics for Alzheimer’s disease.
3
Improved XAI integration could refine Alzheimer’s diagnosis, enable more personalized treatment strategies, and advance neuroimaging research.
4
SHAP, LIME, Grad-CAM, and Layer-wise Relevance Propagation are highlighted as key techniques for interpreting neuroimaging models.
5
XAI methods support identification of Alzheimer’s biomarkers, monitoring disease progression, and distinguishing disease stages using MRI and PET.
Research Object
neuroimaging-based artificial intelligence models for Alzheimer’s disease diagnosis, using MRI and PET data
Research Subject
the explainability, transparency, and clinical interpretability of AI-driven Alzheimer’s disease diagnostics, including biomarker identification, disease-progression tracking, and stage differentiation
Publication Details
Publication Date
2025-03-04
Journal
Publisher
ISSN
Cited by
78
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai7
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)2018
Causability and explainability of artificial intelligence in medicine2019
Brain Imaging in Alzheimer Disease2012
Interpreting artificial intelligence models: a systematic review on the application of LIME and SHAP in Alzheimer’s disease detection2024
A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer’s disease2021
Layer-Wise Relevance Propagation for Explaining Deep Neural Network Decisions in MRI-Based Alzheimer's Disease Classification2019
Explainable AI: A review of applications to neuroimaging data2022